These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6190080

  • 1. Axonal transport in neuropathy.
    Jakobsen J, Brimijoin S, Sidenius P.
    Muscle Nerve; 1983 Feb; 6(2):164-6. PubMed ID: 6190080
    [Abstract] [Full Text] [Related]

  • 2. Axonal transport in the motor neurons of rats with neuropathy induced by p-bromophenylacetylurea.
    Nagata H, Brimijoin S.
    Ann Neurol; 1986 May; 19(5):458-64. PubMed ID: 2424360
    [Abstract] [Full Text] [Related]

  • 3. Abnormalities of axonal transport: are they a cause of peripheral nerve disease?
    Brimijoin WS.
    Mayo Clin Proc; 1982 Nov; 57(11):707-14. PubMed ID: 6182427
    [Abstract] [Full Text] [Related]

  • 4. Toxic neurofilamentous axonopathies and fast anterograde axonal transport. I. The effects of single doses of acrylamide on the rate and capacity of transport.
    Sickles DW.
    Neurotoxicology; 1989 Nov; 10(1):91-101. PubMed ID: 2475836
    [Abstract] [Full Text] [Related]

  • 5. [Abnormalities of axonal transport as pathogenesis of axonal degeneration in peripheral neuropathy].
    Nagata H.
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1355-7. PubMed ID: 1966015
    [Abstract] [Full Text] [Related]

  • 6. Axonal transport of enzymes and labeled proteins in experimental axonopathy induced by p-bromophenylacetylurea.
    Jakobsen J, Brimijoin S.
    Brain Res; 1981 Dec 14; 229(1):103-22. PubMed ID: 6171326
    [Abstract] [Full Text] [Related]

  • 7. Altered spectrum of retrogradely transported axonal proteins in p-bromophenylacetylurea neuropathy.
    Oka N, Brimijoin S.
    Neurochem Res; 1993 Jun 14; 18(6):675-80. PubMed ID: 8389990
    [Abstract] [Full Text] [Related]

  • 8. [Impairment of rapid axonal transport and concomitant anomaly of smooth endoplasmic reticulum in acrylamide induced neuropathy].
    Chrétien M, Souyri F, Patey G.
    C R Seances Acad Sci D; 1979 Feb 19; 288(7):689-92. PubMed ID: 88279
    [Abstract] [Full Text] [Related]

  • 9. Acrylamide neuropathy and changes in the axonal transport and muscular content of the molecular forms of acetylcholinesterase.
    Couraud JY, Di Giamberardino L, Chretien M, Souyri F, Fardeau M.
    Muscle Nerve; 1982 Apr 19; 5(4):302-12. PubMed ID: 6178969
    [Abstract] [Full Text] [Related]

  • 10. Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea.
    Brimijoin S, Mintz KP.
    Muscle Nerve; 1984 Apr 19; 7(9):725-32. PubMed ID: 6100457
    [Abstract] [Full Text] [Related]

  • 11. Early and dose-dependent decrease of retrograde axonal transport in acrylamide-intoxicated rats.
    Jakobsen J, Sidenius P.
    J Neurochem; 1983 Feb 19; 40(2):447-54. PubMed ID: 6185637
    [Abstract] [Full Text] [Related]

  • 12. Neurotoxicity of halogenated phenylacetylureas is linked to abnormal onset of rapid axonal transport.
    Nagata H, Brimijoin S.
    Brain Res; 1986 Oct 15; 385(1):136-42. PubMed ID: 2429734
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the effects of acrylamide and experimental diabetes on the retrograde axonal transport of proteins in the rat sciatic nerve: analysis by two-dimensional polyacrylamide gel electrophoresis.
    Logan MJ, McLean WG.
    J Neurochem; 1988 Jan 15; 50(1):183-9. PubMed ID: 2447233
    [Abstract] [Full Text] [Related]

  • 14. Synaptophysin immunoreactive axonal swelling in p-bromophenylacetylurea-induced neuropathy.
    Jortner BS, Dyer K, Walton A, Ehrich M.
    Neurotoxicology; 1997 Jan 15; 18(1):161-8. PubMed ID: 9215998
    [Abstract] [Full Text] [Related]

  • 15. Tubulomembranous lesions in p-bromophenylacetylurea neuropathy reflect local stasis of fast axonal transport: evidence from electron microscopic autoradiography.
    Oka N, Brimijoin WS.
    Mayo Clin Proc; 1992 Apr 15; 67(4):341-8. PubMed ID: 1372380
    [Abstract] [Full Text] [Related]

  • 16. Position sensitivity of de-efferented muscle spindles in experimental acrylamide neuropathy.
    Lowndes HE, Baker T, Cho ES, Jortner BS.
    J Pharmacol Exp Ther; 1978 Apr 15; 205(1):40-8. PubMed ID: 204769
    [Abstract] [Full Text] [Related]

  • 17. Nervous system abnormality and nervous disease in diabetes.
    Jakobsen J, Sidenius P, Lundbaek K.
    Acta Endocrinol Suppl (Copenh); 1980 Apr 15; 238():123-31. PubMed ID: 6159763
    [Abstract] [Full Text] [Related]

  • 18. Pathology of the peripheral neuropathy induced by p-bromophenylacetylurea.
    Troncoso JC, Griffin JW, Price DL, Hess-Kozlow KM.
    Lab Invest; 1982 Feb 15; 46(2):215-23. PubMed ID: 7062723
    [Abstract] [Full Text] [Related]

  • 19. A proposal for a classification of neuropathies according to their axonal transport abnormalities.
    Jakobsen J, Sidenius P, Braendgaard H.
    J Neurol Neurosurg Psychiatry; 1986 Sep 15; 49(9):986-90. PubMed ID: 2428941
    [Abstract] [Full Text] [Related]

  • 20. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
    Lee PG, Hohman TC, Cai F, Regalia J, Helke CJ.
    Exp Neurol; 2001 Jul 15; 170(1):149-61. PubMed ID: 11421592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.